Rare diseases
Investigational molecules
Locations
Ul. Marii Curie Sklodowskiej 9, 85-094 Bydgoszcz, Poland
Szpital Uniwersytecki Nr 1 Im. Dr. A. Jurasza W Bydgoszczy in Bydgoszcz, Poland specialises in clinical trials of conditions such as Acute lymphocytic leukaemia, Acute coronary syndrome, Acute myeloid leukaemia, Heart failure with preserved ejection fraction, and other specialisations. This site conducts important research.
The medical center is at the forefront of cardiovascular medicine, focusing on innovative treatments for conditions such as acute myocardial infarction and acute heart failure. The center's research aims to improve patient outcomes through advanced therapeutic strategies.
By integrating cutting-edge research with clinical practice, the center contributes significantly to the development of new treatment protocols and the enhancement of existing therapies.
Specializing in oncology and hematology, the center conducts pivotal research in the treatment of acute lymphoblastic leukemia and myeloid leukemia in children, particularly those with Down syndrome. The focus is on improving survival rates and reducing treatment-related toxicities.
The center's research efforts are instrumental in advancing therapeutic options and enhancing the quality of life for pediatric patients.
In the field of gastroenterology, the center is renowned for its research on ulcerative colitis and pancreatic exocrine insufficiency. The focus is on developing effective maintenance therapies and improving gastrointestinal health post-surgery.
Through its research, the center aims to provide innovative solutions that enhance patient care and treatment efficacy.
The center is a leader in neurology, with a particular emphasis on neurofibromatosis type 1 and related conditions. Research is focused on improving diagnostic techniques and therapeutic interventions for symptomatic, inoperable plexiform neurofibromas.
By advancing understanding and treatment of neurological disorders, the center plays a crucial role in enhancing patient outcomes.
In nephrology, the center's research is dedicated to addressing primary membranous nephropathy. The focus is on evaluating the efficacy of novel therapeutic agents to achieve complete remission in patients.
The center's work in this area is pivotal in developing new treatment paradigms and improving patient care.
Specializing in urology, the center explores innovative treatments for urinary incontinence post-radical prostatectomy. Research focuses on the safety and effectiveness of somatic cell-based therapies.
The center's research efforts are crucial in advancing therapeutic options and improving quality of life for patients.
The center is at the cutting edge of immunology and allergy research, particularly in the treatment of chronic inducible urticaria. The focus is on developing effective therapies for patients inadequately controlled by standard treatments.
Through its research, the center aims to provide innovative solutions that enhance patient care and treatment efficacy.
Clinical trials currently enrolling participants at this site.
Long-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
PolandA Study to Test if Rinvecalinase Alfa is Safe and Works for Treating Acute Ischemic Stroke in Patients with Moderate Stroke Severity
PolandStudy on Rituximab for Adults with Relapsing Steroid-Sensitive Nephrotic Syndrome
PolandPolandTesting Stem Cell Transplant Methods and Medications Including Ruxolitinib and Blinatumomab for Children and Young Adults with Acute Lymphoblastic Leukemia
PolandStudy comparing high-dose and low-dose aspirin with prasugrel and aspirin combination in patients after coronary artery bypass grafting surgery
PolandStudy Comparing Inotuzumab Ozogamicin to Drug Combination for Children with High-Risk Relapsed B-cell Acute Lymphoblastic Leukemia
PolandStudy on Pancreatic Enzyme Replacement Therapy for Adults with Pancreatic Exocrine Insufficiency After Pancreatic Surgery
PolandStudy of Ruxolitinib and Chemotherapy Drug Combination for Children with Acute Lymphoblastic Leukemia and JAK/STAT Pathway Activation
PolandStudy on Lymphoblastic Lymphoma Treatment in Children and Adolescents Using Dexamethasone, Prednisone, and PEG-Asparaginase
PolandStudy on Methotrexate and Dexamethasone for Infants Under One Year with Acute Lymphoblastic Leukemia
PolandStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
PolandGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
